Search Results

Tamoxifen Induced Severe Hypertriglyceridemia in a Male Patient with Breast Carcinoma

Authors: Santeufemia, Davide A.; Capobianco, Giampiero; Dessole, Salvatore; Tolu, Francesco; Fadda, Giovanni Maria; Di Meglio, Giovanni; Farris, Antonio

Source: The Breast Journal, Volume 15, Number 6, November/December 2009 , pp. 675-676(2)

Publisher: Blackwell Publishing

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II

Author: Zhou, Shu-Feng

Source: Clinical Pharmacokinetics, Volume 48, Number 12, 1 December 2009 , pp. 761-804(44)

Publisher: Adis International

Is tamoxifen a genotoxic carcinogen in women?

Author: Brown, Karen

Source: Mutagenesis, Volume 24, Number 5, 7 September 2009 , pp. 391-404(14)

Publisher: Oxford University Press

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Authors: Rabaglio, M.; Sun, Z.; Price, K. N.; Castiglione-Gertsch, M.; Hawle, H.; Thrlimann, B.; Mouridsen, H.; Campone, M.; Forbes, J. F.; Paridaens, R. J.; Colleoni, M.; Pienkowski, T.; Nogaret, J.-M.; Lng, I.; Smith, I.; Gelber, R. D.; Goldhirsch, A.; Coates, A. S.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1489-1498(10)

Publisher: Oxford University Press

Substrate Specificity, Regulation, and Polymorphism of Human Cytochrome P450 2B6

Authors: Mo, Sui-Lin; Liu, Ya-He; Duan, Wei; Wei, Ming Q.; Kanwar, Jagat R.; Zhou, Shu-Feng

Source: Current Drug Metabolism, Volume 10, Number 7, September 2009 , pp. 730-753(24)

Publisher: Bentham Science Publishers

Structure, Function, Regulation and Polymorphism of Human Cytochrome P450 2A6

Authors: Di, Yuan M.; Chow, Vivian D.e.h-W.e.i.; Yang, Li-Ping; Zhou, Shu-Feng

Source: Current Drug Metabolism, Volume 10, Number 7, September 2009 , pp. 754-780(27)

Publisher: Bentham Science Publishers

Comment to Dr. Yatham regarding tamoxifen listed as a third-line recommendation for the pharmacological treatment of acute mania

Authors: Shen, Cheng Che; Bai, Ya Mei; Su, Tung-Ping

Source: Bipolar Disorders, Volume 11, Number 7, November 2009 , pp. 773-775(3)

Publisher: Blackwell Publishing

CANMAT/ ISBD treatment guidelines: response to Shen et al.

Authors: Yatham, Lakshmi N.; Kennedy, Sidney H.

Source: Bipolar Disorders, Volume 11, Number 7, November 2009 , pp. 775-775(1)

Publisher: Blackwell Publishing

Breast Cancer Chemoprevention: Current Perspectives

Authors: Oyama, Takeru; Yasui, Yumiko; Tanaka, Takuji

Source: Current Enzyme Inhibition, Volume 5, Number 4, December 2009 , pp. 198-208(11)

Publisher: Bentham Science Publishers

Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay

Authors: Stevenson, Susan; Sharpe, David T.; Julie Thornton, M.

Source: Experimental Dermatology, Volume 18, Number 11, November 2009 , pp. 988-990(3)

Publisher: Blackwell Publishing

Tamoxifen: Photodermatitis in an elderly patient: case report

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 25-25(1)

Publisher: Adis International

DNA methylation as a biomarker in breast cancer

Authors: Martens, John WM; Margossian, Astrid L; Schmitt, Manfred; Foekens, John; Harbeck, Nadia

Source: Future Oncology, Volume 5, Number 8, October 2009 , pp. 1245-1256(12)

Publisher: Future Medicine

Oncologists favour endocrine therapy as age increases and health declines.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 6-6(1)

Publisher: Adis International

Zoledronic acid worth it for HR+ breast cancer

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 590, 2009-10-31 , pp. 9-9(1)

Publisher: Adis International

Data on a potential increase in the risk of breast cancer due to an inhibitory effect of tamoxifen on estrogen receptor beta

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 3-3(1)

Publisher: Adis International

Antineoplastics: Osteonecrosis and osteomyelitis (first report with epirubicin): case report

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 6-6(1)

Publisher: Adis International

Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells

Authors: Kim, Mi Ra; Choi, Hoo-Kyun; Cho, Kyoung Bin; Kim, Hyung Sik; Kang, Keon Wook

Source: Cancer Science, Volume 100, Number 10, October 2009 , pp. 1834-1841(8)

Publisher: Blackwell Publishing

Tamoxifen: Purpuric vasculitis, arthritis and cholestasis: case report

Source: Reactions, Volume 1, Number 1270, 2009-09-19 , pp. 36-36(1)

Publisher: Adis International

Although tamoxifen, raloxifene and tibolone significantly reduce the risk of breast cancer, the use of each drug is associated with distinct adverse effects

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 3-3(1)

Publisher: Adis International

Tamoxifen: Uterine cancer: 5 case reports

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 31-32(2)

Publisher: Adis International